Building a Personalized Supplement Protocol: Evidence Tiers and Genetic Considerations

The supplement industry is a $180 billion mess of marketing claims and underdosed proprietary blends, but buried under the noise there's a core set of interventions with genuine evidence. The key is stratifying by evidence quality and adjusting based on individual genetics and bloodwork — not following a generic influencer stack. Here's the framework I've built after reviewing the literature.

Tier 1 — Strong evidence, broad applicability: Vitamin D3 (2,000-5,000 IU/day, adjusted to maintain serum 25(OH)D at 40-60 ng/mL) — deficiency affects ~42% of US adults and is associated with all-cause mortality, immune dysfunction, and bone loss. Test first, dose accordingly, and retest at 3 months. Take with K2 (100-200mcg MK-7) to direct calcium to bones rather than arteries. Omega-3 fatty acids (EPA+DHA, 2-4g/day) — REDUCE-IT trial showed 25% cardiovascular risk reduction at 4g/day EPA; the VITAL trial was less impressive at lower doses, suggesting dose matters. Get the omega-3 index test (target >8%). Magnesium (200-400mg/day as glycinate, threonate, or malate — avoid oxide, it's a laxative) — involved in 300+ enzymatic reactions, ~50% of Americans are insufficient. Threonate specifically crosses the blood-brain barrier and has preliminary evidence for cognitive benefits (Bhatt et al., 2024). Creatine monohydrate (3-5g/day) — not just for athletes. Emerging evidence for cognitive benefits, neuroprotection, and cellular energy metabolism. The most studied supplement in history with an excellent safety profile.

Tier 2 — Moderate evidence, more individual: NMN (nicotinamide mononucleotide, 500-1000mg/day) or NR (nicotinamide riboside, 300-600mg/day) — NAD+ precursors. The Sinclair lab's mouse data is compelling; human trials show NAD+ elevation but clinical endpoints are still unclear. The METRO trial (2024) showed improved muscle function in older adults at 800mg NMN. Worth trying if budget allows, but not yet definitive. Berberine (500mg 2-3x/day with meals) — activates AMPK similarly to metformin. Meta-analyses show meaningful effects on blood glucose (comparable to metformin in some studies), LDL reduction, and gut microbiome composition. Genuinely useful for metabolic health. Glycine (3-5g before bed) — improves sleep quality, supports glutathione synthesis, and shows anti-inflammatory effects. Cheap and well-tolerated. Taurine (1-3g/day) — the Singh et al. (2023) Science paper showed taurine levels decline with age and supplementation extended lifespan in mice by 10-12%. Human correlational data is supportive but causal evidence in humans is pending.

Tier 3 — Emerging or requires medical supervision: Rapamycin (discussed in my earlier journal entry) — the strongest mouse longevity data of any compound, but requires physician oversight, periodic bloodwork, and careful dosing (typically 3-6mg weekly, not daily). Not for self-experimentation. Metformin (off-label, 500-1500mg/day) — the TAME trial is ongoing and will be definitive. Current evidence is mixed: observational data from diabetics is encouraging, but metformin may blunt exercise adaptations (the MASTERS trial showed reduced muscle gains). Consider only if metabolically indicated. Senolytics (dasatinib + quercetin, fisetin) — clearing senescent cells is a compelling mechanism, but human dosing protocols are speculative. Unity Biotechnology's clinical trials have had mixed results. Fisetin (500mg intermittently, not daily) is the most accessible option but evidence is preliminary.

Genetic adjustments are where this gets personalized: MTHFR C677T or A1298C variants — switch all folate supplementation to methylfolate (L-5-MTHF, 400-800mcg) and use methylcobalamin instead of cyanocobalamin. Avoid folic acid fortified foods where possible. COMT Met/Met — these individuals are slow methylators; they may need more methylation support but can also be sensitive to excess methyl donors (SAMe, TMG) — start low. VDR variants (rs2228570, rs1544410) — may require higher vitamin D doses to achieve target serum levels. APOE e4 — prioritize omega-3s (higher doses), limit saturated fat more aggressively, consider additional cardiovascular monitoring. Testing protocol: get comprehensive bloodwork at baseline (CBC, CMP, lipid panel, hs-CRP, homocysteine, insulin, HbA1c, vitamin D, omega-3 index, thyroid panel, iron studies). Start supplements one at a time with 4-week gaps to identify responders vs. non-responders. Retest at 3 months, then every 6-12 months. Red flags: don't combine berberine with metformin (additive hypoglycemia risk), watch for magnesium-medication interactions (antibiotics, bisphosphonates), and never take high-dose fat-soluble vitamins (A, E) without testing.